Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Simson Pharma Limited, is an unlisted public company incorporated on 19 April, 2018. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 15.00 cr and the total paid-up capital is INR 10.00 cr.
Simson Pharma Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 17.3% over the previous year. At the same time, it's book networth has increased by 46.93%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Manga Rani Penchala
Shareholder
|
05106236 | 8 years |
| Director | Bhavika Penchala
Shareholder
|
07866501 | 8 years |
| Managing Director | Satyanarayana Rao Penchala
Shareholder
|
05106241 | 8 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
IDBI Bank Limited
No. of Loans: 1
Total Amount : 1.2 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| WISH LABORATORIES LLP |
Active
|
1.0 L | 2 | Maharashtra |
| SIMSOL MEDIPHARMA LLP |
Active
|
1.0 L | 3 | Maharashtra |
| SIMSON LIFE SCIENCES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Telangana |
| AMERTHA LIFE SCIENCES LLP |
Active
|
1.0 L | 1 | Maharashtra |
Read more
The incorporation date of SIMSON PHARMA LIMITED is 19 April, 2018
The authorized share capital of SIMSON PHARMA LIMITED is INR ₹ 15.0 Cr.
The paid-up capital of SIMSON PHARMA LIMITED is INR ₹ 10.0 Cr.
The registered address of SIMSON PHARMA LIMITED is GALA NO-B/307, 3RD FLOOR, NEW SARITA BLDG. PRABHAT INDL COMPLEX, DAHISAR EAST, Mumbai City, MUMBAI, Maharashtra, India, 400068 - 400068
The CIN number of SIMSON PHARMA LIMITED is U24230MH2018PLC308280.